🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

37+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

ℹ
Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 17 of 37 recruiting trials for “Aggressive primary cutaneous T-cell lymphoma”

RecruitingNCT05157581 ↗

Extracorporeal Photopheresis in Sezary Syndrome

👨‍⚕️ Oleg E Akilov, MD, PhD, University of Pittsburgh📍 3 sites📅 Started Apr 2023View details ↗
RecruitingNCT06421571 ↗

The Mechanism of Action of Chlormethine (CL) Gel in the Treatment of MF-CTCL Adult Patients

🏥 National and Kapodistrian University of Athens📍 1 site📅 Started Feb 2023View details ↗
Phase 2RecruitingNCT04930653 ↗

Extracorporeal Photopheresis and Mogamulizumab for the Treatment of Erythrodermic Cutaneous T Cell Lymphoma

👨‍⚕️ Christiane R Querfeld, City of Hope Medical Center📍 3 sites📅 Started Oct 2022View details ↗
Phase 2RecruitingNCT05357794 ↗

Effectiveness of Concurrent Ultra-Low-Dose Total-Skin Electron Beam Therapy and Brentuximab Vedotin Given Quarterly Over 12 Months for Patients With Mycosis Fungoides

👨‍⚕️ Bouthaina Dabaja, MD, M.D. Anderson Cancer Center📍 1 site📅 Started Oct 2022View details ↗
NARecruitingNCT05333367 ↗

MORPHEE : Mechanisms of Cell Death Induced by Extracorporeal Photochemotherapy

🏥 Centre Hospitalier Universitaire de Besancon📍 1 site📅 Started Apr 2022View details ↗
Phase 1RecruitingNCT05296304 ↗

A Study of Bexarotene Combined With Radiotherapy in People With Mycosis Fungoides

👨‍⚕️ Brandon Imber, MD, Memorial Sloan Kettering Cancer Center📍 3 sites📅 Started Mar 2022View details ↗
NARecruitingNCT04087629 ↗

StrataCTX® as a Steroid Sparing Device

👨‍⚕️ Larisa J. Geskin, MD, Columbia University📍 1 site📅 Started Jul 2021View details ↗
Phase 2RecruitingNCT05680558 ↗

Photopheresis in Early-stage Mycosis Fungoides

👨‍⚕️ Larisa Geskin, MD, Columbia University📍 1 site📅 Started May 2021View details ↗
RecruitingNCT04904146 ↗

Predictive and Prognostic Biomarkers in Patients With Mycosis Fungoides and Sézary Syndrome.

🏥 Lund University Hospital📍 1 site📅 Started Apr 2021View details ↗
Phase 2RecruitingNCT04256018 ↗

Mogamulizumab + Low-Dose Total Skin Electron Beam Tx in Mycosis Fungoides & Sézary Syndrome

👨‍⚕️ Youn H Kim, MD, Stanford University📍 1 site📅 Started Mar 2020View details ↗
NARecruitingNCT04045470 ↗

A Pilot of a Microdevice For In Situ Candidate Drug Screening in Cutaneous Lesions of T-Cell Lymphoma

👨‍⚕️ Cecilia Larocca, MD, Dana-Farber Cancer Institute📍 1 site📅 Started Dec 2019View details ↗
RecruitingNCT03932279 ↗

Characterization of the Microbiome in Cutaneous T Cell Lymphoma

👨‍⚕️ Alan Zhou, MD, Northwestern University📍 1 site📅 Started Jan 2019View details ↗
Phase 2RecruitingNCT03587844 ↗

Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients

👨‍⚕️ Alison Moskowitz, MD, Memorial Sloan Kettering Cancer Center📍 8 sites📅 Started Jul 2018View details ↗
Phase 2RecruitingNCT03398161 ↗

Ultra Low Dose Radiation Therapy in Treating Patients With Mycosis Fungoides

👨‍⚕️ Bouthaina S Dabaja, M.D. Anderson Cancer Center📍 1 site📅 Started Jan 2018View details ↗
RecruitingNCT02848274 ↗

ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome

👨‍⚕️ Youn H Kim, MD, Stanford University📍 13 sites📅 Started Oct 2016View details ↗
RecruitingNCT02702310 ↗

Low-Dose Total Skin Electron Therapy in Treating Patients With Refractory or Relapsed Stage IB-IIIA Mycosis Fungoides

👨‍⚕️ Austin Kirschner, MD, PhD, Vanderbilt-Ingram Cancer Center📍 1 site📅 Started May 2016View details ↗
RecruitingNCT00177268 ↗

Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

👨‍⚕️ Oleg E Akilov, M.D., PhD, University of Pittsburgh📍 1 site📅 Started Oct 2004View details ↗
← PreviousPage 2 of 2

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →